Recent developments in the treatment of renal cell carcinoma-Reference-Cited by-同舟云学术

Recent developments in the treatment of renal cell carcinoma

Published:2013-10-09 Issue:6 Volume:5 Page:338-353
ISSN:1756-2872
Container-title:Therapeutic Advances in Urology
language:en
Short-container-title:Therapeutic Advances in Urology

Author:

Dutcher Janice P.¹

Affiliation:

1. Associate Director, Cancer Research Foundation, Immediate Past Chair of ECOG-ACRIN Renal Cancer Subcommittee, 750 Kappock Street, # 511, Bronx, NY 10463, USA

Abstract

Renal cell carcinoma (RCC) management has been imbued with new interest, in large part due to the recent success of new treatment options for advanced and metastatic disease. This has also been accompanied by less generally well known advances in the understanding of the molecular characterizations of subtypes of RCC with potential to lead to new therapeutic options. Additionally, the urologic oncology community is focusing on nephron-sparing surgical approaches with limited surgery if possible, and in conjunction with interventional radiologists, on ablative procedures for incidentally determined small renal masses. This report reviews some of the new biologic findings of adenocarcinoma of the kidney, and reviews the new therapeutics which continue to change the landscape for treatment of RCC.

Publisher

SAGE Publications

Subject

Urology

Link

http://journals.sagepub.com/doi/pdf/10.1177/1756287213505672

Reference117 articles.

1. Early Clinical Development of ARQ 197, a Selective, Non–ATP-Competitive Inhibitor Targeting MET Tyrosine Kinase for the Treatment of Advanced Cancers

2. Birt-Hogg-Dubé Syndrome: Clinicopathologic Findings and Genetic Alterations

3. Prolonged survival with personalized immunotherapy (AGS-003) in combination with sunitinib in unfavorable risk metastatic RCC (mRCC).

4. Aberrant Nuclear Immunoreactivity for TFE3 in Neoplasms With TFE3 Gene Fusions

5. Gene Mutations in the Succinate Dehydrogenase Subunit SDHB Cause Susceptibility to Familial Pheochromocytoma and to Familial Paraganglioma

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Affinity fine-tuning anti-CAIX CAR-T cells mitigate on-target off-tumor side effects;Molecular Cancer;2024-03-16

2. Evolution of cell therapy for renal cell carcinoma;Molecular Cancer;2024-01-09

3. Treatment Options for Renal Cell Carcinoma: Mechanisms and Outcomes;annals of urologic oncology;2023-06-28

4. Circ_0101692 knockdown retards the development of clear cell renal cell carcinoma through miR-384/FN1 pathway;Translational Oncology;2023-02

5. A Cuproptosis-Related Gene Model For Predicting the Prognosis of Clear Cell Renal Cell Carcinoma;Frontiers in Genetics;2022-08-11